1. van Hulzen et al., 2017, ‘Genetic overlap between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence from GWAS meta-analysis’,Biological Psychiatry
  2. Mogavero et al., 2016, ‘Clock Genes, ADHD, and aggression’, Neurosci Biobehav Rev
  3. Chen et al., 2017, ‘Shared familial risk factors between attention-deficit/
    hyperactivity disorder and overweight/obesity – a population-based familial coaggregation study in Sweden’, Journal of Child Psychology and Psychiatry
  4. Rydell et al., 2017, ‘Genetic and environmental contributions to the association
    between ADHD and affective problems in early childhood—A Swedish population-based twin study’, Am J Med Genet.
  5. Ortega et al., 2017, ‘The Fat but Fit paradox: what we know and don’t know about it’, Br J Sports Med
  6. Landaas et al., 2016, ‘Vitamin levels in adults with ADHD’, BJPsych Open
  7. Yule et al., 2017, ‘Examining the association between attention deficit hyperactivity
    disorder and substance use disorders: A familial risk analysis’, Journal of Psychiatric Research
  8. von Rhein et al., 2017, ‘Network-Level Assessment of Reward-Related
    Activation in Patients with ADHD and Healthy Individuals’, Human Brain Mapping
  9. Garcia-Martínez et al., 2016, ‘Preliminary evidence for association of genetic variants
    in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder’, Transl Psychiatry
  10. Zayats et al., 2016, ‘Exome chip analyses in adult attention deficit hyperactivity disorder’, Transl Psychiatry
  11. Cabana-Domínguez et al., 2016, ‘A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence’, Sci Rep
  12. Merker et al., 2017, ‘SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder’, J Child Psychol Psychiatry
  13. Faraone et al., 2017, ‘The Familial Co-Aggregation of Attention-Deficit/Hyperactivity Disorder and Intellectual Disability: A Register-Based Family Study’, J Am Acad Child Adolesc Psychiatry
  14. Hoogman et al., 2017, ‘Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis’, Lancet Psychiatry
  15. Kurrikoff et al., 2018, ‘Association of the COMT Val108/158Met genotype with professional career and education: The Val-allele is more frequent in managers and in enterprising occupations’, Personality and Individual Differences
  16. Patak et al., 2017, ‘SLC9A9 Co-expression modules in autism-associated brain regions’, Autism Res
  17. Oldehinkel et al., 2016, ‘Functional connectivity in cortico-subcortical brain networks underlying reward processing in attention-deficit/hyperactivity disorder’, Neuroimage Clin
  18. Solberg et al., 2018, ‘Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder’, Acta Psychiatr Scand.
  19. Du Rietz et al., 2018, ‘Association of polygenic risk for attention-deficit / hyperactivity disorder with co-occuring traits and disorders’, Biol. Psych.
  20. Mayer et al., 2018, ‘Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial’, Trials.
  21. Du Rietz et al., 2018, ‘Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurringTraits and Disorders’, Biol Psychiatry Cogn Neurosci Neuroimaging.
  22. Pineda-Cirera et al., 2018, ‘Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample’, Drug Alcohol Depend.
  23. Cabana-Domínguez et al., 2018, ‘Association of the PLCB1 gene with drug dependence’, Sci Rep.
  24. Cabana-Domínguez et al., 2018, ‘MiR-9, miR-153 and miR-124 are downregulated by acute exposure to cocaine in a dopaminergic cell model and may contribute to cocaine dependence’, Transl Psychiatry. 
  25. Martin et al., 2018, ‘A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder.’, Biol Psychiatry. 
  26. Demontis et al., 2019, ‘Discovery of the first genome-wide significant risk loci for ADHD’, Nature Genetics
  27. Chen et al., 2018, ‘Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study’, PLoS One.
  28. Chen et al., 2018, ‘Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden’, Psychol Med. 
  29. Solberg et al., 2018, ‘Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder’, Acta Psychiatr Scand.
  30. Corominas et al., 2018, ‘Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing’, Mol Psychiatry
  31. Ortega et al., 2018, ‘Role of Physical Activity and Fitness in the Characterization and Prognosis of the Metabolically Healthy Obesity Phenotype: a Systematic Review and Meta-Analysis’, Prog Cardiovasc Dis
  32. Ostergaard et al., 2017, ‘Teenage Parenthood and Birth Rates for Individuals With and Without Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study’, J Am Acad Child Adolesc Psychiatry
  33. Shadrin et al., 2018, ‘Novel Loci Associated With Attention-Deficit/Hyperactivity Disorder Are Revealed by Leveraging Polygenic Overlap With Educational Attainment’, J Am Acad Child Adolesc Psychiatry
  34. Faraone et al., 2018, ‘The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities’, Neurosci Biobehav Rev
  35. Zhang-James et al., 2018, ‘An integrated analysis of genes and functional pathways for aggression in human and rodent models’, Mol Psychiatry
  36. Faraone et al., 2018, ‘Genetics of attention deficit hyperactivity disorder’, Mol Psychiatry
  37. Fernandez-Castillo et al., 2017, ‘RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior’, Eur Neuropsychopharmacol
  38. Sullivan et al., 2018, ‘Psychiatric Genomics: An Update and an Agenda’, Am J Psychiatry 
  39. Franke et al., 2018, ‘Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan’, Eur Neuropsychopharmacol
  40. Meier et al., 2018, ‘Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood’, Br J Psychiatry
  41. Ottosen et al., 2019, ‘Sex Differences in Comorbidity Patterns of Attention-Deficit/Hyperactivity Disorder’, J Am Acad Child Adolesc Psychiatry
  42. Tokko et al., 2018, ‘Relapse of drunk driving and association with traffic accidents, alcohol-related problems, and biomarkers of impulsivity’, Acta Neuropsychiatr
  43. Migueles et al., 2018, ‘Comparability of published cut-points for the assessment of physical activity: Implications for data harmonization’, Scand J Med Sci Sports
  44. Grimm et al., 2018, ‘Recent developments in the genetics of attention-deficit hyperactivity disorder’, Psychiatry and Clinical Neurosciences
  45. Zhang-James et al., 2019, ‘Oral Methylphenidate Treatment of an Adolescent ADHD Rat Model Does Not Alter Cocaine-Conditioned Place Preference during Adulthood: A Negative Report’, J Psychiatr Brain Sci
  46. Libutzki et al., 2019, ‘Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis’, Eur Psychiatr
  47. Torrico et al., 2019, ‘Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes’, J Psychiatry Neurosci
  48. Cabana-Domínguez et al., 2019, ‘Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions’, Prog Neuropsychopharmacol Biol Psychiatry
  49. Arcos-Burgos et al., 2019, ‘ADGRL3 (LPHN3) variants predict substance use disorder’, Transl Psychiatr
  50. Treur et al., 2019, ‘Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization’, Addiction Biology
  51. Hartman et al., 2019, ‘Stress Exposure and the Course of ADHD from Childhood to Young Adulthood: Comorbid Severe Emotion Dysregulation or Mood and Anxiety Problems’, Journal of Clinical Medicine
  52. Hegvik et al., 2019, ‘Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment.’, Molecular Psychiatry
  53. Solberg et al., 2019, ‘Patterns of Psychiatric Comorbidity and Genetic
    Correlations Provide New Insights Into Differences Between Attention-Deficit / Hyperactivity Disorder and Autism Spectrum Disorder’, Biological Psychiatry
  54. Sánchez-Mora et al., 2019, Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells”, Neuropsychopharmacology

Disseminating results